A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy

This publication has 12 references indexed in Scilit:

• The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx
  European Journal Of Cancer, 1993
• Improved Control of Emesis and Quality of Life with Ondansetron in Breast Cancer
  Oncology, 1993
• Loss of local control with prolongation in radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.
  Journal of Clinical Oncology, 1991
• Comparison of the 5-Hydroxytryptamine₃(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
  New England Journal of Medicine, 1990
• A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: A randomized, double-blind study
  European Journal of Cancer and Clinical Oncology, 1990
• Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation
  Clinical Oncology, 1990
• ONDANSETRON WITH AND WITHOUT DEXAMETHASONE TO TREAT CHEMOTHERAPY-INDUCED EMESIS
  The Lancet, 1989
• A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea
  Clinical Radiology, 1987
• Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy.
  Radiology, 1984